(NASDAQ: ICUI) Icu Medical's forecast annual revenue growth rate of 3.7% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.33%.
Icu Medical's revenue in 2026 is $2,183,051,000.On average, 10 Wall Street analysts forecast ICUI's revenue for 2026 to be $55,872,561,166, with the lowest ICUI revenue forecast at $53,471,591,662, and the highest ICUI revenue forecast at $57,873,369,086. On average, 10 Wall Street analysts forecast ICUI's revenue for 2027 to be $58,298,540,769, with the lowest ICUI revenue forecast at $55,497,409,681, and the highest ICUI revenue forecast at $61,274,742,550.
In 2028, ICUI is forecast to generate $60,924,601,164 in revenue, with the lowest revenue forecast at $57,698,298,393 and the highest revenue forecast at $64,876,196,806.